India, May 4 -- For patients managing cancer, autoimmune conditions, or complex metabolic disorders, reliable access to specialty medicines is not a convenience but a clinical necessity. Chennai-based startup MrMed, India's specialty and super-specialty medicine platform, is making a significant infrastructure bet on Bengaluru - among its top two revenue markets, as part of a broader strategy to deepen access to critical care medicines, expanding last-mile reach, improving delivery timelines, and strengthening supply reliability across one of its most active demand clusters. At the centre of this expansion is a new storage and distribution hub in Central Bengaluru, an 850 sq ft facility strategically located for rapid dispatch across the ...